Physician profile
John J Whitehead
NPI 1891866679
$8,208.20
in general payments reported to CMS, 2019-2025
13 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,621 · 2020: $1,107 · 2021: $1,467 · 2022: $1,581 · 2023: $584 · 2024: $1,102 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,367 · Honoraria: $64.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,367.46 |
| Honoraria | $64.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,963.20 | 2019-2025 | Clareon, Clareon Panoptix Pro, Acrysof Iq Panoptix Uv Iol |
| Glaukos Corporation | $593.59 | 2021-2025 | Idosetr, Istent Infinite |
| Allergan, INC. | $552.80 | 2019-2021 | |
| New World Medical,INC. | $368.30 | 2019-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Rxsight INC | $356.88 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Abbvie INC. | $112.46 | 2023-2025 | Durysta |
| Sight Sciences, INC. | $65.02 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Iridex Corporation | $61.26 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.51 | 2019-2021 | |
| Ivantis, INC | $33.84 | 2021 | |
| Horizon Therapeutics Plc | $23.27 | 2022 | |
| Quidel Corporation | $20.63 | 2019 | |
| Bausch & Lomb Americas INC. | $16.44 | 2025 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Whitehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.